Replies to post #13367 on Sorrento Therapeutics Inc (SRNE)

[dia76ca]

In Benzinga interview Dr.Ji emphasized SEMDEXA aiming for Breakthrough Designation followed by marketing approval within 6 months. Also Mpro oral antiviral enter clinic in April with signs it does not have drug/drug interactions of the Pfizer drug. COVISHIELD covers all covid variants. COVIMARK approval packages before US FDA and Health Canada. AND application for COVIMARK APPROVAL IN CHINA...gigantic market!